Skip to main content
Caplight Logo









Inari

Inari

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://inari.com

Last Round

Series G

Jan 7, 2025

Est. Valuation

$2.17B

Total Funding Raised

$813M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Inari is an agricultural biotechnology company that develops gene-edited seeds for major row crops using a proprietary SEEDesign platform that combines AI-powered predictive design and multiplex gene editing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

gene editingagtechagricultural biotechnologyseed technologypredictive modelingmultiplex gene editingcontrolled environment agricultureCEAcrop geneticscrisprgenomic dataplant breedingbiotech startupsustainable agriculturetechnology licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Book a demo to explore historical pricing and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Book a demo

For institutional investors. Book with your work email.

Inari Comparables

Compare Inari with similar companies based on industry and business-model similarity.

Inari comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wild Bioscience
80%
Cibus, Inc.
80%
Ohalo Genetics
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Inari Funding Rounds

Historical fundraising activity

Book a demo to see all 8 rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ignacio Martinez

Co-Founder, Chairman, Founding President and CEO

Founding Team

Lisa Nunez Safarian

Chief Executive Officer, Board Director

Executive Team

Ponsi Trivisvavet

Chief Executive Officer

Executive Team

Claudia Nari

Chief Product Officer

Executive Team

For institutional investors. Book with your work email.

Inari Investors

Notable investors and investment history

Inari investors
InvestorRounds
Investment Corporation of DubaiSeries C, Series D
CPP InvestmentsSeries F, Series E
Sage Hill InvestorsSeries E
Sage Hill CapitalSeries E
EDBISeries C
State of Michigan Retirement SystemSeries G, Series F
Acre Venture PartnersSeries C, Series B
Book a demo to see all investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 3, 2026

    Recognized for the second consecutive year by AgTech Breakthrough.

  • Apr 4, 2026

    Named 'AgTech Company of the Year' by AgTech Breakthrough.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • has_issues_withOct 2, 2026

    Corteva accused Inari of improperly accessing patented seed materials from depositories in Delaware, an allegation resolved through a confidential settlement on Sep 28th '26.

  • has_issues_withSep 29, 2026

    Corteva and Inari settled a lawsuit accusing Inari of improperly obtaining Corteva’s patented seed materials, genetically modifying them, and seeking to commercialize the resulting products; Inari must destroy related biological materials and assign Corteva intellectual property associated with edited versions.

Book a demo to see all news

For institutional investors. Book with your work email.

Inari Filings

Explore SEC and related filing metadata, where available.

Inari filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Inari's valuation, stock price, and market status.

Is Inari a public or private company?

Inari is a private company.

What is the current stock price of Inari?

Inari is a private company, so its shares have no public market price. Caplight tracks Inari's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Inari worth (valuation)?

Inari's valuation is estimated at $2.2B based on funding round data.

Can I buy Inari stock?

Inari shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Inari's last funding round?

Inari's most recent funding round was Series G on January 7, 2025.

Who are the main investors in Inari?

Key investors in Inari include CPP Investments, Flagship Pioneering, K2 HealthVentures.

Will Inari IPO soon?

No public IPO plans have been announced for Inari.

How can I track Inari secondary market activity?

Caplight tracks bids, offers, and trades in Inari's shares on secondary markets.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range206
Year Founded2016
Last FundingJan 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?